FDA Inspection
Pharmasol CorporationPharmasol Corporation – FDA Inspection, Sep 5, 2018
Record Details
This FDA Inspection record concerns Pharmasol Corporation, with an inspection on September 5, 2018, issued by the New England District Office, covering animal drugs & feeds.
- People
- Jonathan G. Matrisciano (FDA Associated Person)
- Margaret M. Doherty (Issuing Officer)
- Sean R. Marcsisin (FDA Associated Person)
View Company Profile
ID · df5edf3f-03e4-4a20-ab02-aa4be83c8ac8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1064526
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.122(a)Written procedures not followed
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmasol Corporation
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 14, 2021 | OAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Pharmasol Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.